ECCO News

  • 2017 Nr1 Cover ECCO News
    Issue 1/2017
  • 2017 Nr2 Cover ECCO News
    Issue 2/2017
  • 2017 Nr3 Cover ECCO News
    Issue 3/2017
  • cover ECCO 042017
    Issue 4/2017
  • 2016 Nr1 Cover ECCO News
    Issue 1/2016
  • 2016 Nr2 Cover ECCO News
    Issue 2/2016
  • 2016 Nr3 Cover ECCO News
    Issue 3/2016
  • 2016 Nr4 Cover ECCO News
    Issue 4/2016
  • 2015 Nr1 Cover ECCO News
    Issue 1/2015
  • 2015 Nr2 Cover ECCO News
    Issue 2/2015
  • 2015 Nr3 Cover ECCO News
    Issue 3/2015
  • 2015 Nr4 Cover ECCO News
    Issue 4/2015
  • 2014 Nr1 Cover ECCO News
    Issue 1/2014
  • 2014 Nr2 Cover ECCO News
    Issue 2/2014
  • 2014 Nr3 Cover ECCO News
    Issue 3/2014
  • 2014 Nr4 Cover ECCO News
    Issue 4/2014
  • 2013 Nr1 Cover ECCO News
    Issue 1/2013
  • 2013 Nr2 Cover ECCO News
    Issue 2/2013
  • 2013 Nr3 Cover ECCO News
    Issue 3/2013
  • 2013 Nr4 Cover ECCO News
    Issue 4/2013
  • 2012 Nr1 Cover ECCO News
    Issue 1/2012
  • 2012 Nr2 Cover ECCO News
    Issue 2/2012
  • 2012 Nr3 Cover ECCO News
    Issue 3/2012
  • 2012 Nr4 Cover ECCO News
    Issue 4/2012
  • 2011 Nr1 Cover ECCO News
    Issue 1/2011
  • 2011 Nr2 Cover ECCO News
    Issue 2/2011
  • 2011 Nr3 Cover ECCO News
    Issue 3/2011
  • 2011 Nr4 Cover ECCO News
    Issue 4/2011
  • 2010 Nr1 Cover ECCO News
    Issue 1/2010
  • 2010 Nr2 Cover ECCO News
    Issue 2/2010
  • 2010 Nr3 Cover ECCO News
    Issue 3/2010
  • 2010 Nr4 Cover ECCO News
    Issue 4/2010
  • 2009 Nr1 Cover ECCO News
    Issue 1/2009
  • 2010 Nr2 Cover ECCO News
    Issue 2/2009
  • 2010 Nr3 Cover ECCO News
    Issue 3/2009
  • 2009 Nr4 Cover ECCO News
    Issue 4/2009
  • 2008 Nr1 Cover ECCO News
    Issue 1/2008
  • 2008 Nr2 Cover ECCO News
    Issue 2/2008
  • 2008 Nr3 Cover ECCO News
    Issue 3/2008
  • 2008 Nr4 Cover ECCO News
    Issue 4/2008
  • 2007 Nr1 Cover ECCO News
    Issue 1/2007
  • 2007 Nr2 Cover ECCO News
    Issue 2/2007
  • 2007 Nr3 Cover ECCO News
    Issue 3/2007
  • 2007 Nr4 Cover ECCO News
    Issue 4/2007

ECCO News keeps ECCO Members up-to-date on what is going on within the organisation and reports on IBD activities taking place within Europe. Since Spring 2006, ECCO News has maintained the flow of information between Members of the organisation. 

ECCO News is an important part of the European Crohn’s and Colitis Organisation’s ambition to create a European standard of IBD care and to promote knowledge and research in the field of IBD. ECCO Members automatically receive this publication four times a year. 

Latest ECCO News Content


12December2017

Letter from the ECCO President

Julián Panés, ECCO President

Julian PanesJulián Panés  ©  ECCO

Dear ECCO friends,

We are witnessing an exciting period in the development of new therapies for Inflammatory Bowel Diseases. New therapeutic targets, and new classes of drugs, are being integrated into our therapeutic armamentarium. However, when we consider the proportion of patients who respond to induction therapy and, among those, the fraction who achieve remission during maintenance, the percentage of initially treated patients in whom the disease is satisfactorily controlled over one year does not exceed 15%30%.

Posted in ECCO News, Volume 12, Issue 4, Letters from the ECCO President

12December2017

ECCO’18 – Come to Vienna for IBD!

02 Congress Banner

 

The 13th Congress of ECCO in Vienna is coming closer and so is the late registration deadline. Benefit from the late registration fee by registering up until January 31, 2018 (after this date the onsite registration fees will apply).

 

Posted in Volume 12, Issue 4, ECCO News, ECCO'18, Congress News

12December2017

ECCO activities at UEG Week 2017

Laurent Peyrin-Biroulet, Editor, ECCO News

Laurent Peyrin BirouletLaurent Peyrin-Biroulet
© ECCO

I am happy to inform all ECCO members that the Governing Board started working while everybody was still on the plane! This year, we arrived on Friday afternoon and could already discuss numerous points. First, it was decided to continue increasing the amount of money for grants to foster exchange across ECCO centres and support innovative scientific projects. 

Posted in Volume 12, Issue 4, ECCO News, Governing Board, Committee News

12December2017

We have MORE THAN a dream – your pioneer IBD platform, UR-CARE, is online NOW!

Julián Panés, ECCO President; Filip Baert, UR-CARE Steering Committee

07 UR CARE LOGO website

Dear friends and colleagues,

UR-CARE is online NOW!

This international database offered to you by ECCO’s research unit (IBDIM) has been designed for your patient records and your research studies.

Posted in ECCO News, Volume 12, Issue 4, UR-CARE News

12December2017

News from BIOCYCLE

Edouard Louis

Portraits3
Edouard Louis © ECCO

The BIOCYCLE project has now been ongoing for almost 2.5 years. This project, funded by the European Commission under the Horizon 2020 programme, aims at exploring different aspects of the question of treatment de-escalation in moderate-severe Crohn’s Disease, first requiring a combination therapy with anti-TNF and antimetabolites to control the disease. Once the disease has been stabilised, an unsolved question is to whether it is possible to de-escalate therapy. This question is important for several reasons including safety, tolerance, quality of life or costs to name the most prominent. 

Posted in ECCO News, Volume 12, Issue 4, EU Projects

12December2017

Fecal Transplantation Using a Novel Conditioning Method for Donor and Recipient in Mild to Moderate Treatment Refractory Colitis in IBD

Arie Levine, ECCO Grant Winner

Arie LevineArie Levine © ECCO

Fecal microbial transplantation (FMT) is an exciting and evolving methodology to transform the microbiota in microbiota-related diseases. The rationale behind FMT is "transfer of a healthy microbiota" from a donor to a patient with IBD, leading to a change in recipient microbiota towards that of a healthy donor. However, current methods are simplistic. Random healthy donors do not necessarily have an appropriate microbiota, and transferred microbiota may not colonise the recipient’s gut. Diet can rapidly degrade certain taxa or increase others, such that if the recipient diet is not appropriate, donor microbiota expansion may not occur or functionality may be impaired.

Posted in Volume 12, Issue 4, ECCO News, SciCom, Committee News

12December2017

SWEETEN: Glycans as novel immunomodulators in IBD

Salome de Pinho, ECCO Grant Winner

PortraitsSalome de Pinho © ECCO

Aims of the research

The current therapeutic strategies for Inflammatory Bowel Disease (IBD) are limited by effectiveness and/or toxicity, and the selection of patients for therapy remains a major challenge. These clinical concerns highlight the unmet need to identify key mechanisms (molecular markers) capable of being selectively targeted with new and optimised therapies. Glycosylation is a major post-translational mechanism characterised by the addition of carbohydrate structures (glycans) to essentially all cells [1]. Evidence in other immune-mediated disorders has shown that protein N-glycosylation, particularly branched N-glycans, regulates T cell immune response and controls the threshold of T cell activation [2].

Posted in Volume 12, Issue 4, ECCO News, SciCom, Committee News

12December2017

Predicting response to treatment in patients with IBD

Bram Verstockt, ECCO Grant Winner

Portraits2Bram Verstockt © ECCO

Aims of the research

The introduction of new non-anti-TNF agents such as the anti-adhesion and anti-IL-12/IL-23 molecules will increase the therapeutic armamentarium for patients with IBD. It is nevertheless anticipated that clinical response and adverse events will vary significantly between individuals. Therefore, we need predictors of efficacy and safety so that we can select the right drug at the right time for the right patient. Targeted strategies in patients with poor prognostic factors and head-to-head trials are currently lacking.

Posted in Volume 12, Issue 4, ECCO News, SciCom, Committee News

12December2017

ECCO CONFER Cases Round 4

MASTER ECCO CONFER Cases Logo
Call for proposal of rare cases now open!

ECCO COllaborative Network For Exceptionally Rare Case Reports (CONFER) is an initiative to identify, assemble and report together rare IBD cases of clinical relevance, which are otherwise seldom reported. By joining forces with the many Members and supporters of ECCO, a joint report of all similar rare cases can result in a large case series that will advance our knowledge about these uncommon patients.

Posted in Volume 12, Issue 4, ECCO News, SciCom, Committee News

12December2017

52nd ECCO Educational Workshop in Kaunas, Lithuania

Antonio López Sanromán, EduCom Member

13 MASTER Button Kaunas

September 15, 2017

The ECCO Workshop in Lithuania was organised in the quiet and beautiful city of Kaunas. Philip Hendy, from London, and Antonio López-Sanromán, from Madrid and an EduCom Officer, joined the local faculty (Limas Kupcinkas, Gediminas Giudelis and Laimas Jonaitis). 

Posted in ECCO News, Volume 12, Issue 4, Committee News, EduCom